{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:05:28Z","timestamp":1786118728869,"version":"build-2736575974"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1097\/01.crd.0000218853.05856.b6","type":"journal-article","created":{"date-parts":[[2007,2,7]],"date-time":"2007-02-07T05:33:44Z","timestamp":1170826424000},"page":"55-61","source":"Crossref","is-referenced-by-count":42,"title":["Giant Cell Arteritis"],"prefix":"10.1097","volume":"15","author":[{"given":"Robert T.","family":"Eberhardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep","family":"Dhadly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210203","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00002281-200401000-00006","article-title":"Giant cell arteritis: strategies in diagnosis and treatment.","volume":"16","author":"Nordborg","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"R2-1-20210203","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.bor.0000197996.04709.4e","article-title":"Large-vessel involvement in giant cell arteritis.","volume":"18","author":"Bongartz","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"R3-1-20210203","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","article-title":"Polymyalgia rheumatica and giant-cell arteritis.","volume":"347","author":"Salvarani","year":"2002","journal-title":"N Engl J Med"},{"key":"R4-1-20210203","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/art.1780261007","article-title":"The epidemiology of giant cell arteritis: report of a ten-year study in Shelby County, Tennessee.","volume":"26","author":"Smith","year":"1983","journal-title":"Arthritis Rheum"},{"key":"R5-1-20210203","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/art.1780300308","article-title":"Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county: a prospective investigation, 1982\u20131985.","volume":"30","author":"Boesen","year":"1987","journal-title":"Arthritis Rheum"},{"key":"R6-1-20210203","first-page":"S9","article-title":"Epidemiology of polymyalgia rheumatica.","volume":"18","author":"Cimmino","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"R7-1-20210203","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/ard.30.3.224","article-title":"Temporal arteritis in a large necropsy series.","volume":"30","author":"Ostberg","year":"1971","journal-title":"Ann Rheum Dis"},{"key":"R8-1-20210203","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R9-1-20210203","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/ard.60.4.367","article-title":"Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period.","volume":"60","author":"Gonzalez-Gay","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"R10-1-20210203","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.20227","article-title":"Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period.","volume":"51","author":"Salvarani","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R11-1-20210203","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0889-857X(21)00478-6","article-title":"Histopathologic specificity of systemic vasculitis.","volume":"21","author":"Lie","year":"1995","journal-title":"Rheum Dis Clin North Am"},{"key":"R12-1-20210203","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/art.1780370411","article-title":"HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis.","volume":"37","author":"Weyand","year":"1994","journal-title":"Arthritis Rheum"},{"key":"R13-1-20210203","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/1529-0131(199905)42:5<844::AID-ANR2>3.0.CO;2-M","article-title":"Arterial wall injury in giant cell arteritis.","volume":"42","author":"Weyand","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R14-1-20210203","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0167-5273(00)00198-4","article-title":"Pathogenic principles in giant cell arteritis.","volume":"75","author":"Weyand","year":"2000","journal-title":"Int J Cardiol"},{"key":"R15-1-20210203","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z","article-title":"Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment.","volume":"41","author":"Gonzalez-Gay","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R16-1-20210203","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9343(01)00770-7","article-title":"Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients.","volume":"111","author":"Liozon","year":"2001","journal-title":"Am J Med"},{"key":"R17-1-20210203","first-page":"205","article-title":"Polymyalgia rheumatica and giant cell arteritis: a 5 year epidemiologic and clinical study in Reggio Emilio, Italy.","volume":"5","author":"Salvaroni","year":"1987","journal-title":"Clin Exp Rheumatol"},{"key":"R18-1-20210203","doi-asserted-by":"crossref","first-page":"806","DOI":"10.7326\/0003-4819-83-6-806","article-title":"Large artery involvement in giant cell (temporal) arteritis.","volume":"83","author":"Klein","year":"1975","journal-title":"Ann Intern Med"},{"key":"R19-1-20210203","first-page":"S13","article-title":"Predictors of cerebrovascular accidents in giant cell arteritis in a defined population.","volume":"22","author":"Pego-Reigosa","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"R20-1-20210203","first-page":"2356","article-title":"Vertebrobasilar ischemia and structural abnormalities of the vertebral arteries in active temporal arteritis and polymyalgia rheumatica: an ultrasonographic case\u2013control study.","volume":"32","author":"Pfadenhauer","year":"2005","journal-title":"J Rheumatol"},{"key":"R21-1-20210203","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/01.md.0000145369.25558.b5","article-title":"Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis.","volume":"83","author":"Gonzalez-Gay","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"R22-1-20210203","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00005792-200301000-00002","article-title":"Audiovestibular manifestations in giant cell arteritis: a prospective study.","volume":"82","author":"Amor-Dorado","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"R23-1-20210203","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-122-7-199504010-00004","article-title":"Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis: a population-based study.","volume":"122","author":"Evans","year":"1995","journal-title":"Ann Intern Med"},{"key":"R24-1-20210203","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.md.0000145366.40805.f8","article-title":"Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study.","volume":"83","author":"Gonzalez-Gay","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"R25-1-20210203","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1002\/art.11480","article-title":"Mortality of large-artery complication (aortic aneurysm, aortic dissection, and\/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years.","volume":"48","author":"Nuenninghoff","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R26-1-20210203","first-page":"422","article-title":"Thoracic aortic aneurysm and rupture in giant cell arteritis: a descriptive study of 41 cases.","volume":"37","author":"Evan","year":"1994","journal-title":"Arthritis Rheum"},{"key":"R27-1-20210203","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0003-4975(03)00695-7","article-title":"Repair of acute type A aortic dissection associated with temporal arteritis.","volume":"76","author":"Berry","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"R29-1-20210203","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00006324-199901000-00024","article-title":"Myocardial infarction and coronary artery involvement in giant cell arteritis.","volume":"76","author":"Freddo","year":"1999","journal-title":"Optom Vis Sci"},{"key":"R30-1-20210203","first-page":"647","article-title":"Giant cell arteritis confined to intramural coronary arteries: unforeseen hazards myocardial protection.","volume":"43","author":"Kumar","year":"2002","journal-title":"J Cardiovasc Surg"},{"key":"R31-1-20210203","first-page":"S41","article-title":"Predictors of left ventricular dysfunction in patients with Takayasu's or giant cell aortitis.","volume":"22","author":"Pfizenmaier","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"R32-1-20210203","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/ard.48.8.667","article-title":"Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica\/giant cell arteritis on presentation and during follow up.","volume":"48","author":"Kyle","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"R33-1-20210203","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/1529-0131(200104)45:2<140::AID-ANR166>3.0.CO;2-2","article-title":"Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study.","volume":"45","author":"Salvarani","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R34-1-20210203","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/1529-0131(200005)43:5<1041::AID-ANR12>3.0.CO;2-7","article-title":"Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity.","volume":"43","author":"Weyand","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R35-1-20210203","first-page":"1100","article-title":"Soluble interleukin 2 receptors in polymyalgia rheumatica\/giant cell arteritis: clinical and laboratory correlations.","volume":"19","author":"Salvarani","year":"1992","journal-title":"J Rheumatol"},{"key":"R36-1-20210203","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jcp.53.2.137","article-title":"The importance of skip lesions in temporal arteritis.","volume":"53","author":"Poller","year":"2000","journal-title":"J Clin Pathol"},{"key":"R37-1-20210203","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/sarh.2001.16650","article-title":"Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy.","volume":"30","author":"Gonzalez-Gay","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"R38-1-20210203","first-page":"278","article-title":"Spectrum of aging changes in temporal arteries. Its significance, in interpretation of biopsy of temporal artery.","volume":"90","author":"Lie","year":"1970","journal-title":"Arch Pathol Lab Med"},{"key":"R39-1-20210203","doi-asserted-by":"crossref","first-page":"987","DOI":"10.7326\/0003-4819-120-12-199406150-00003","article-title":"How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis?","volume":"120","author":"Achkar","year":"1994","journal-title":"Ann Intern Med"},{"key":"R40-1-20210203","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/0003-4819-129-5-199809010-00001","article-title":"Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis.","volume":"129","author":"Rao","year":"1998","journal-title":"Ann Intern Med"},{"key":"R41-1-20210203","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJM199711063371902","article-title":"Color duplex ultrasonography in the diagnosis of temporal arteritis.","volume":"337","author":"Schmidt","year":"1997","journal-title":"N Engl J Med"},{"key":"R42-1-20210203","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7326\/0003-4819-137-4-200208200-00006","article-title":"Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis?","volume":"137","author":"Salvarani","year":"2002","journal-title":"Ann Intern Med"},{"key":"R43-1-20210203","first-page":"2177","article-title":"Duplex sonography of the temporal and occipital artery in the diagnosis of temporal arteritis. A prospective study.","volume":"30","author":"Pfadenhauer","year":"2003","journal-title":"J Rheumatol"},{"key":"R44-1-20210203","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/rheumatology\/keh513","article-title":"Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis.","volume":"44","author":"Narvaez","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"R45-1-20210203","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/01.bor.0000147282.02411.c6","article-title":"Use of ultrasonography and positron emission tomography in the diagnosis and assessment of large-vessel vasculitis.","volume":"17","author":"Schmidt","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"R46-1-20210203","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/rheumatology\/31.2.103","article-title":"Prevention of blindness in giant cell arteritis by corticosteroid treatment.","volume":"31","author":"Myles","year":"1992","journal-title":"Br J Rheumatol"},{"key":"R47-1-20210203","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.ophtha.2005.01.036","article-title":"Poor prognosis of visual outcome after visual loss from giant cell arteritis.","volume":"112","author":"Danesh-Meyer","year":"2005","journal-title":"Ophthalmology"},{"key":"R48-1-20210203","first-page":"303","article-title":"Efficacy and adverse effects of different corticosteroid dose regimens in temporal arteritis: a retrospective study.","volume":"15","author":"Nesher","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"R49-1-20210203","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/ard.47.9.733","article-title":"Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients).","volume":"47","author":"Delecoeuillerie","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"R50-1-20210203","first-page":"1340","article-title":"Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatic and temporal arteritis.","volume":"17","author":"Lundberg","year":"1990","journal-title":"J Rheumatol"},{"key":"R51-1-20210203","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/S0140-6736(00)02210-8","article-title":"Steroid therapy for visual loss in patients with giant-cell arteritis.","volume":"355","author":"Hayreh","year":"2000","journal-title":"Lancet"},{"key":"R52-1-20210203","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7326\/0003-4819-82-5-613","article-title":"Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study.","volume":"82","author":"Hunder","year":"1975","journal-title":"Ann Intern Med"},{"key":"R53-1-20210203","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/art.1780401022","article-title":"Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica.","volume":"40","author":"Gabriel","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R54-1-20210203","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-134-2-200101160-00010","article-title":"Combined treatment of giant-cell arteritis with methotrexate and prednisone: a randomized, double-blind, placebo-controlled trial.","volume":"134","author":"Jover","year":"2001","journal-title":"Ann Intern Med"},{"key":"R55-1-20210203","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/art.10262","article-title":"A multicenter, randomized, double-blind, placebo-controlled study of adjuvant methotrexate treatment for giant cell arteritis.","volume":"46","author":"Hoffman","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R56-1-20210203","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10067-005-1115-8","article-title":"Infliximab as monotherapy in giant cell arteritis.","volume":"25","author":"Uthman","year":"2006","journal-title":"Clin Rheumatol"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00045415-200703000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:25:54Z","timestamp":1786033554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045415-200703000-00001"}},"subtitle":["Diagnosis, Management, and Cardiovascular Implications"],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.crd.0000218853.05856.b6","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}